CAMILLE DONQUE: Open Payments
NPI 1184399354 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,731 in 80 payments from 24 companies in 2025. Trend: 2023 $613 · 2024 $1,279 · 2025 $1,731
Food & beverage: $1,631Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $270 |
| AstraZeneca Pharmaceuticals LP | 10 | $220 |
| Novartis Pharmaceuticals Corporation | 10 | $208 |
| GENZYME CORPORATION | 6 | $142 |
| SpringWorks Therapeutics, Inc. | 6 | $127 |
| ABBVIE INC. | 5 | $86 |
| Merck Sharp & Dohme LLC | 4 | $69 |
| PFIZER INC. | 3 | $68 |
| Geron Corporation | 2 | $64 |
| Incyte Corporation | 3 | $63 |
Products named: OGSIVEO, DARZALEX, KISQALI, SARCLISA, Fabhalta, EPKINLY, RYTELO, JAKAFI.
Industry payments across AZ — which companies pay providers there.
